About the Journal
The Biologic Orthopedics Journal focuses on biologics across the spectrum of orthopedic care. From the existing biologics, such as bone marrow aspirate, platelet-rich plasma, and adult stem cells, to those newly evolving in science, as well as the innovations in how they are used, there is much to be learned. With even newer biologic treatment options being developed, understanding what they are, how they benefit patient care, and how effectively and safely to incorporate them in practice, are all areas of coverage for this journal.
Vision for the journal and its associated nonprofit association
Researchers, scientists, and practitioners in the field of biologic orthopedics are empowered, excited, and producing phenomenal results in the world.
Regenerative medicine in general and, biologic orthopedics in particular, already prove their potential to improve health, cause lasting positive outcomes, and deliver economic benefits for healthcare. This relatively new field faces challenges in developing protocols, policies and procedures that are universally accepted and grounded in evidence-based research. The journal seeks to be part of the solution for those challenges.
The Biologic Orthopedics Journal Association, which provides the home for the journal supports the education, advocacy, training, and other related activity associated with broad issues in biologic orthopedics to realize the vision of empowered people and science in the field of biologic orthopedics.
Mission for the journal/nonprofit
The journal provides a platform for the voices of scientists, researchers, and practitioners promoting the very best of biologic orthopedics, with a focus on safety, efficacy.
The mission is achieved by producing a journal that:
1. Showcases the very best ideas and insights from evidence-based science and research
2. Legitimizes the sound and safe practices of the newest evolutions in biologic orthopedics and that illegitimizes the unsafe, unsound practices in the field.
3. Educates doctors and practitioners globally to encourage and even ensure the power of biologics is harnessed productively, shared widely, and beneficial for many
The Editors-in-Chief of the respective journal first reviews all articles submitted to it to ensure the content is suitable for the journal. Once reviewed, the Editor elects to either move the article through to the peer review process or reject articles, based on quality and the editorial contribution the article provides the journal. Once the Editor feel an article meets the publishing criteria of the Journal, the article will move on for peer review. All peer review is double blind. Reviewers can elect to reject the article, accept the article with changes, or accept the article as is. Reviewer comments are shared with the author and once the author has made any suggested changes to the article, the Editor gives final approval for publication. At this point the author is then charged the APC. Please see peer review process for more details.
DPG Open Access journals publish original research, select review articles, case-reports, conference abstracts, letters-to-the editor, book reviews, and special supplemental issues. All content must be accepted by the Editor-in-Chief and is subject to plagiarism-checking and the peer review process.
All articles published in DPG Open Access journals are licensed under
Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of articles published in all DPG titles is retained by the author. The author grants DPG the rights to publish the article and identify itself as the original publisher. The author grants DPG exclusive commercial rights to the article. The author grants any non-commercial third party the rights to use the article freely provided original author(s) and citation details are cited.
An initial in-house quality control check deals with issues such as competing interests, financial disclosures, plagiarism, etc. Submissions may be returned to authors for queries, and will not be seen by our Editorial Board or peer reviewers until they pass this quality control check.
After the quality control check, the Editor of the journal reviews the article, and decides if the article is accepted for review or rejected. In some cases, where an article is submitted in English, by an author not fluent in English, the article may be sent back with the recommendations to have the article edited for English, and resubmitted.
Once an article has been accepted, it will be sent to a selected editorial board member, based on experience and expertise. The Editorial Board member will then either act as one of two peer reviewers, or will select two peer reviewers to review the article. Reviews are double blind.
Questions, comments, and suggestions from peer reviewers will be submitted to the Editor for consideration, after which the article and peer review remarks will be sent to the author.
Once the peer reviewer, Editorial Board member, and Editor are satisfied with the author's changes, the article will be published.
It is our goal to have accepted articles published within 45 days, depending on the level of response from the authors.
Articles are published in both a web version and PDF format.